Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.235

-3.5%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Savant	7/11/2025 12:48:44 PM
	of 3576

The consensus price target of analysts on Wall Street is $4, which implies an increase of 65.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4 and $4 respectively. As a result, GERN is trading at a discount of -189.86% off the target high and -189.86% off the low. An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 5.60%. While earnings are projected to return 52.95% in 2025. How Will Geron Corp (NASDAQ: GERN) Look After It Drops -266.67% From Its Highs? – Marketing Sentinel

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next